Imatinib is a multi-target inhibitor of v-Abl, c-Kit, and PDGFR (IC50: 0.6 µM, 0.1 µM, and 0.1 µM, respectively). Imatinib is used to treat chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs), and a number of other malignancies.
Molecular Weight:
530.06
CAS Number:
[862366-25-4]
Formula:
C29H32ClN7O
Target:
Others
T22859
* VAT and and shipping costs not included. Errors and price changes excepted